American Vanguard (AVD) to Release Quarterly Earnings on Monday

American Vanguard (NYSE:AVD) is scheduled to announce its earnings results after the market closes on Monday, November 11th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

American Vanguard (NYSE:AVD) last announced its quarterly earnings data on Thursday, August 8th. The basic materials company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). American Vanguard had a negative net margin of 0.60% and a positive return on equity of 1.85%. The firm had revenue of $128.21 million during the quarter, compared to analyst estimates of $134.20 million. On average, analysts expect American Vanguard to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

American Vanguard Price Performance

Shares of NYSE:AVD opened at $5.77 on Friday. American Vanguard has a twelve month low of $4.95 and a twelve month high of $14.28. The stock’s 50 day moving average is $5.52 and its 200-day moving average is $7.58. The company has a quick ratio of 1.08, a current ratio of 2.22 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $166.38 million, a price-to-earnings ratio of -48.08 and a beta of 0.88.

Insider Buying and Selling at American Vanguard

In related news, Director Keith M. Rosenbloom acquired 33,555 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The stock was acquired at an average price of $5.66 per share, for a total transaction of $189,921.30. Following the completion of the acquisition, the director now owns 1,047,410 shares of the company’s stock, valued at approximately $5,928,340.60. This represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other American Vanguard news, Director Keith M. Rosenbloom bought 33,555 shares of the business’s stock in a transaction on Wednesday, August 28th. The stock was purchased at an average price of $5.66 per share, for a total transaction of $189,921.30. Following the completion of the transaction, the director now directly owns 1,047,410 shares of the company’s stock, valued at $5,928,340.60. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Keith M. Rosenbloom purchased 104,492 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was bought at an average cost of $5.74 per share, with a total value of $599,784.08. Following the completion of the acquisition, the director now directly owns 1,168,682 shares of the company’s stock, valued at approximately $6,708,234.68. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 163,047 shares of company stock worth $938,205. Corporate insiders own 10.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on AVD shares. Lake Street Capital began coverage on shares of American Vanguard in a report on Monday, July 22nd. They set a “buy” rating and a $14.00 price objective for the company. StockNews.com raised shares of American Vanguard from a “sell” rating to a “hold” rating in a research report on Wednesday, September 25th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $16.67.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.